Related Experiment Video

Updated: Jul 6, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Treatment of recurrent thyroid cancers--is there a light in the horizon?

Rodrigo Kraft Rovere1, Ahmad Awada

  • 1Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Current Opinion in Oncology
|April 9, 2008
PubMed
Abstract

Insights

New targeted therapies show promise for advanced thyroid cancer unresponsive to traditional chemotherapy. Success depends on understanding molecular drivers and well-designed clinical trials for these novel agents.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Thyroid cancer incidence is rising faster than other cancers, with poor response rates to conventional chemotherapy for recurrent or advanced disease.
  • Anaplastic thyroid cancer has seen no survival improvement in four decades, highlighting the need for novel therapeutic strategies.
  • Molecular studies are revealing new therapeutic targets and insights into thyroid cancer biology.

Purpose of the Study:

  • To review recent advancements in chemotherapy for advanced and recurrent thyroid cancer.
  • To discuss emerging molecular-targeted agents with therapeutic potential.
  • To evaluate the promise of new targeted approaches for thyroid cancer treatment.

Main Methods:

  • Review of current literature on thyroid cancer chemotherapy and molecular targeted therapies.
  • Analysis of molecular signalling pathways and cancer cell biology relevant to thyroid cancer.
  • Examination of ongoing clinical trials for novel therapeutic agents.

Main Results:

  • Chemotherapy has yielded limited breakthroughs in advanced/recurrent thyroid cancer since the 1970s.
  • Anaplastic thyroid cancer survival rates have remained stagnant for over 40 years.
  • Several novel agents targeting specific molecular pathways are under investigation.

Conclusions:

  • New molecular-targeted therapies offer potential for treating advanced thyroid cancer resistant to traditional treatments.
  • The efficacy of these targeted agents relies on identifying specific molecular abnormalities driving carcinogenesis.
  • Well-designed clinical trials are crucial for validating the success of these promising new agents.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.